7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2010-06-30 2005-06-30 
      
    		                                                        
      operating activities
    		                                                        
      net income
    		42,211,000 47,466,000 50,128,000 61,032,000 54,377,000 49,068,000 49,458,000 53,046,000 53,559,000 53,276,000 51,951,000 51,023,000 55,272,000 52,086,000 50,215,000 45,325,000 57,755,000 35,514,000 40,873,000 44,589,000 43,706,000 37,046,000 38,058,000 33,252,000 33,925,000 -139,274,000 38,167,000 30,841,000 34,466,000 -39,687,000 314,793,000 30,705,000 33,759,000 11,090,000 31,641,000 32,195,000 -5,531,000 13,936,000 27,995,000 31,803,000 26,173,000 16,732,000 16,001,000 3,130,000 32,792,000 20,692,000 19,349,000 12,257,000 19,244,000 14,655,000 -15,000 9,510,000 12,949,000 14,768,000 9,605,000 4,007,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                        
      depreciation and amortization
    		7,663,000 7,666,000 7,252,000 6,868,000 7,929,000 8,124,000 7,843,000 7,646,000 7,643,000 7,543,000 8,130,000 8,248,000 8,384,000 8,485,000 8,050,000 7,963,000 7,594,000 7,537,000 7,609,000 7,551,000 7,467,000 7,331,000 7,381,000 7,222,000 7,061,000 7,526,000 7,887,000 7,994,000 8,372,000 8,045,000 8,340,000 8,534,000 8,507,000 7,092,000 5,852,000 6,016,000 6,832,000 6,198,000 6,071,000 5,687,000 5,720,000 2,961,000 3,277,000 3,647,000 3,294,000 3,268,000 3,285,000 3,359,000 3,296,000 3,295,000 3,051,000 2,563,000 2,570,000 2,550,000 2,547,000 2,635,000 
      loss on disposal of property and equipment
    		   0 78,000 5,000  40,000   77,000 81,000 13,000  52,000 1,000 26,000  79,000 89,000 42,000  165,000 -1,000 20,000  160,000 36,000 1,000                            
      deferred and other income taxes
    		17,384,000 5,827,000 7,131,000 2,914,000 3,752,000 612,000                                                   
      amortization of debt origination costs
    		447,000 442,000 438,000 434,000 428,000 454,000 1,514,000 1,424,000 1,319,000 983,000 815,000 970,000 828,000 1,419,000 1,376,000 676,000 759,000 1,410,000 651,000 1,518,000 1,400,000 1,046,000 1,055,000 860,000 851,000 1,380,000 1,522,000 2,101,000 920,000 1,996,000 1,252,000 1,748,000 1,746,000 2,504,000 1,032,000 2,866,000 2,231,000 3,561,000 1,378,000 1,917,000 2,138,000                
      stock-based compensation costs
    		1,767,000 3,682,000 2,733,000 2,865,000 2,134,000 3,425,000 3,727,000 2,449,000 3,688,000 4,146,000 2,433,000 3,466,000 3,857,000 1,708,000 2,234,000 3,219,000 1,878,000 2,599,000 1,588,000 2,892,000 1,464,000 1,962,000 1,780,000 2,521,000 1,381,000 1,278,000 1,832,000 2,671,000 1,657,000 1,997,000 2,186,000 3,013,000 1,713,000 1,888,000 2,327,000 1,993,000 1,940,000 2,856,000 2,064,000 1,987,000 3,047,000 1,858,000 1,383,000 1,276,000 1,294,000 1,193,000 807,000 992,000 1,060,000 913,000 718,000 703,000 796,000 861,000 857,000  
      non-cash operating lease cost
    		1,932,000 1,947,000 1,925,000 1,892,000 1,724,000 1,706,000 1,655,000 1,678,000 1,572,000 1,244,000 1,713,000 1,491,000 1,493,000 1,672,000 1,683,000 1,660,000 1,691,000 1,720,000 1,775,000 1,756,000 1,831,000 2,669,000 2,963,000 1,816,000 1,338,000                                
      changes in operating assets and liabilities:
    		                                                        
      accounts receivable
    		-29,923,000 27,343,000 -25,201,000 -6,317,000 8,823,000 6,368,000 695,000 -11,432,000 -1,217,000 5,632,000 -8,802,000 -1,197,000 -7,079,000 -2,806,000 12,474,000 -18,443,000 -15,879,000 147,000 7,367,000 -10,376,000 39,734,000 -7,473,000 -1,358,000 174,000 5,808,000 -8,378,000 13,116,000 -3,361,000 -4,357,000 9,030,000 -4,728,000 -10,888,000 1,543,000 -6,564,000 -12,730,000 -4,795,000 5,151,000 -629,000 6,371,000 -6,496,000 2,578,000 6,956,000 1,240,000 14,207,000 -16,782,000 11,070,000 636,000 11,012,000 -15,316,000 -9,214,000 -10,038,000 -741,000 -5,660,000 585,000 2,078,000 11,404,000 
      inventories
    		-5,836,000 -4,441,000 4,071,000 3,086,000 -3,423,000 -13,048,000 10,649,000 13,567,000 7,934,000 -7,711,000 -16,777,000 -7,395,000 -14,415,000 -13,987,000 1,672,000 3,594,000 9,384,000 1,703,000 -1,944,000 3,162,000 51,000 3,747,000 5,583,000 2,539,000 -8,939,000 546,000 -6,936,000 5,158,000 -9,303,000 -3,649,000 4,576,000 -510,000 -2,899,000 6,327,000 -5,926,000 -6,336,000 -4,327,000 4,109,000 -3,276,000 -3,627,000 -211,000 1,540,000 -588,000 -3,083,000 7,537,000 -6,716,000 -5,991,000 -447,000 -156,000 -2,748,000 7,560,000 2,822,000 -2,706,000 -3,966,000 1,086,000  
      prepaid expenses and other current assets
    		-821,000 -10,946,000 -903,000 1,771,000 1,428,000 2,359,000 -5,609,000 1,209,000 1,367,000 -5,181,000 905,000 1,726,000 -3,227,000 7,070,000 -6,095,000 1,522,000 -1,049,000 -1,788,000 1,037,000 1,543,000 -4,019,000  2,249,000 1,207,000 -4,335,000  2,771,000 679,000 623,000  1,812,000 7,519,000 9,604,000  1,037,000 4,415,000 5,697,000 -13,393,000 2,036,000 4,958,000 -1,522,000 -2,203,000 653,000 -5,402,000 2,432,000 187,000 -2,705,000 245,000 5,550,000 6,000 -5,659,000 856,000 438,000 1,356,000 2,029,000  
      accounts payable
    		19,789,000 2,756,000 -560,000 -11,255,000 -8,187,000 591,000 -1,007,000 -5,144,000 -13,221,000 -5,599,000 7,876,000 -1,526,000 2,542,000 15,233,000 2,196,000 7,276,000 -15,551,000 18,447,000 -26,606,000 23,203,000 -32,386,000 12,301,000 -14,556,000 3,159,000 5,306,000 8,794,000 -16,974,000 -12,292,000 16,479,000 1,008,000 -19,044,000 16,032,000 -8,024,000 14,279,000 6,348,000 4,221,000 -3,401,000 6,205,000 -13,034,000 -5,302,000 783,000 -3,096,000 -3,356,000 -160,000 8,022,000 -9,147,000 10,552,000 -1,025,000 15,015,000 135,000 2,735,000 -1,202,000 1,032,000 2,562,000 -659,000  
      accrued liabilities
    		4,736,000 -813,000 2,625,000 3,775,000 2,645,000 -2,061,000 -8,485,000 4,032,000 -3,245,000 -8,519,000 -1,443,000 -736,000 10,524,000 -5,437,000 -9,517,000 6,131,000 18,439,000 -23,148,000 16,361,000 -19,713,000 11,588,000 -8,628,000 14,108,000 -1,000,000 7,616,000 -9,526,000 -1,079,000 13,992,000 347,000 -30,462,000 10,836,000 -10,311,000 -1,558,000 -19,826,000 15,718,000 10,239,000 -3,634,000 -6,535,000 6,650,000 5,693,000 -7,136,000 -3,212,000 1,472,000 -2,868,000 -4,882,000 -5,781,000 -2,577,000 1,281,000 9,199,000 -849,000 8,100,000 -1,854,000 5,317,000 -6,971,000 310,000  
      operating lease liabilities
    		-1,923,000 -1,916,000 -1,909,000 -1,950,000 -1,888,000 -1,883,000 -1,875,000 -1,766,000 -1,748,000 -1,745,000 -1,740,000 -1,599,000 -1,602,000 -1,641,000 -1,657,000 -1,572,000 -1,578,000 -1,633,000 -1,639,000 -1,634,000 -1,812,000 -2,394,000 -3,032,000 -2,030,000 -1,368,000                                
      other
    		  2,399,000 -24,000 -20,000 -944,000     0 1,000 446,000     -8,791,000 1,055,000 -9,000 -109,000    -93,000 -301,000 0 355,000 -108,000                            
      net cash from operating activities
    		57,486,000 79,013,000 61,848,000 65,091,000 69,800,000 54,776,000 66,907,000 71,472,000 62,460,000 48,087,000 54,942,000 57,540,000 58,247,000 63,126,000 66,297,000 61,194,000 69,305,000 59,087,000 49,227,000 52,139,000 75,154,000 56,126,000 57,998,000 50,223,000 52,777,000 50,847,000 43,330,000 39,255,000 55,852,000 54,438,000 47,132,000 54,419,000 54,121,000 7,424,000 40,066,000 49,531,000 50,751,000 37,899,000 45,861,000 47,069,000 43,521,000 29,671,000 30,722,000 25,262,000 32,800,000 22,798,000 36,729,000 40,502,000 45,632,000 14,742,000 19,459,000 14,527,000 18,023,000 15,443,000 20,713,000 9,812,000 
      capex
    		-2,102,000 -838,000 -3,479,000 -1,566,000 -2,027,000 -1,152,000 -3,143,000 -1,996,000 -2,934,000 -1,477,000 -1,803,000 -2,376,000 -1,047,000 -3,161,000 -2,229,000 -2,752,000 -1,500,000 -4,896,000 -5,728,000 -9,066,000 -2,553,000 -5,505,000 -3,233,000 -3,866,000 -1,956,000 -3,341,000 -2,065,000 -2,605,000 -2,469,000 -2,876,000 -4,871,000 -2,231,000 -2,554,000 -1,042,000 -531,000 -509,000 -895,000 -1,028,000 -857,000 -903,000 -780,000 -496,000 -106,000 -339,000 -955,000 -1,364,000 -1,346,000 -3,656,000 -4,068,000 -1,198,000 -248,000 -51,000 -231,000 -76,000 -130,000 0 
      free cash flows
    		55,384,000 78,175,000 58,369,000 63,525,000 67,773,000 53,624,000 63,764,000 69,476,000 59,526,000 46,610,000 53,139,000 55,164,000 57,200,000 59,965,000 64,068,000 58,442,000 67,805,000 54,191,000 43,499,000 43,073,000 72,601,000 50,621,000 54,765,000 46,357,000 50,821,000 47,506,000 41,265,000 36,650,000 53,383,000 51,562,000 42,261,000 52,188,000 51,567,000 6,382,000 39,535,000 49,022,000 49,856,000 36,871,000 45,004,000 46,166,000 42,741,000 29,175,000 30,616,000 24,923,000 31,845,000 21,434,000 35,383,000 36,846,000 41,564,000 13,544,000 19,211,000 14,476,000 17,792,000 15,367,000 20,583,000 9,812,000 
      investing activities
    		                                                        
      purchases of property, plant and equipment
    		-2,102,000 -838,000 -3,479,000 -1,566,000 -2,027,000 -1,152,000 -3,143,000 -1,996,000 -2,934,000 -1,477,000 -1,803,000 -2,376,000 -1,047,000 -3,161,000 -2,229,000 -2,752,000 -1,500,000 -4,896,000 -5,728,000 -9,066,000 -2,553,000 -5,505,000 -3,233,000 -3,866,000 -1,956,000 -3,341,000 -2,065,000 -2,605,000 -2,469,000 -2,876,000 -4,871,000 -2,231,000 -2,554,000                        
      net cash (used in) investing activities
    		-2,929,000 -1,938,000                                                       
      financing activities
    		                                                        
      term loan repayments
    		  0 -60,000,000 -40,000,000 -35,000,000 -75,000,000 -65,000,000 -55,000,000 -30,000,000 -15,000,000 -25,000,000 -15,000,000 -55,000,000 -50,000,000 -475,000,000 -20,000,000 -65,000,000 0 -74,000,000 -56,000,000 -27,000,000    -45,000,000 -55,000,000   -319,000,000 -20,000,000 -55,000,000 -50,000,000 -45,000,000 0 -80,500,000 -50,000,000 -10,000,000 0 -25,000,000 -25,000,000                
      payments of finance leases
    		-539,000 -608,000 -2,637,000 -211,000 -968,000 -720,000 -715,000 -709,000 -704,000 -699,000 -689,000 -683,000 -686,000 -437,000 -649,000 -858,000 -638,000 -525,000 -206,000 -376,000 -336,000 -224,000                                   
      proceeds from exercise of stock options
    		752,000 3,155,000 2,462,000 8,748,000 1,617,000 1,975,000 7,271,000 1,635,000 2,155,000 7,028,000 5,684,000 0 1,489,000 1,322,000 3,011,000 503,000 2,204,000 1,527,000 39,000 69,000 1,216,000 317,000 463,000 269,000 275,000 0 1,903,000 148,000 880,000 154,000 0 1,033,000 433,000 584,000 21,000 18,000 3,405,000 89,000 202,000 70,000 6,328,000 1,294,000 169,000 595,000 4,834,000 309,000 569,000 5,380,000 0 80,000 317,000 1,000 8,000 563,000   
      fair value of shares surrendered as payment of tax withholding
    		-162,000 -4,054,000 0 0 -31,000 -5,801,000 0 0 0 -5,508,000 -16,000 0 -5,450,000 0 0 0 -2,916,000 0 0 0 -1,242,000 0 -94,000 -81,000 -799,000 0 0 0 -2,281,000 0 0 -48,000 -1,027,000 0 -36,000 0 -1,395,000 -42,000 0 0 -2,187,000 -1,171,000 -466,000 0 0 -278,000           
      repurchase of common stock
    		-75,000,000 -34,775,000 -11,313,000 -2,402,000 -11,818,000 -25,976,000 0 0 0 -25,000,000 0 -12,273,000 -37,727,000     -1,993,000 -8,877,000   -6,745,000 0 -21,210,000 -28,766,000 0 0 0 -49,978,000                            
      net cash (used in) financing activities
    		-74,949,000 -36,282,000                                                       
      effects of exchange rate changes on cash and cash equivalents
    		-4,000 825,000 129,000 -2,076,000 711,000 663,000 -605,000 1,415,000 -490,000 -140,000 798,000 -635,000 -1,142,000 449,000 -230,000 -868,000 -310,000 -283,000 1,045,000 893,000 1,942,000 -2,249,000 847,000 -472,000 -19,000 352,000 -406,000 -69,000 -283,000 -44,000 138,000 669,000 337,000 1,470,000 -1,482,000 363,000 -760,000 830,000 478,000 -893,000 82,000 104,000 57,000 -5,000 159,000 -3,000 -67,000 -1,000 38,000 -24,000 32,000 1,000 -30,000 -2,000   
      increase in cash and cash equivalents
    		-20,396,000 41,618,000 47,010,000 -666,000   -17,146,000 3,548,000 5,487,000 -3,909,000 43,916,000 6,573,000 8,684,000   -120,806,000 131,322,000 -29,801,000 35,500,000 -31,338,000 -36,819,000 66,169,000 686,000 -1,137,000 1,512,000 2,858,000 -12,238,000 2,641,000 1,721,000 -12,828,000 2,399,000 -1,158,000 2,280,000 -21,434,000 32,831,000 1,581,000 1,647,000 -21,743,000 26,821,000 554,000 280,000 -12,656,000 -66,022,000 67,520,000 7,527,000 3,636,000      -3,522,000     
      cash and cash equivalents - beginning of period
    		0 97,884,000  0 0 46,469,000  0 0 58,489,000 0 0 27,185,000  0 0 32,302,000  0 0 94,760,000  0 0 27,530,000  0 0 32,548,000  0 0 41,855,000  0 0 27,230,000  0 0 21,318,000 28,331,000  0 0 15,670,000  0 0 19,015,000  0 0 13,334,000   
      cash and cash equivalents - end of period
    		-20,396,000 139,502,000  -666,000 17,284,000 34,256,000  3,548,000 5,487,000 54,580,000 43,916,000 6,573,000 35,869,000  -21,800,000 -120,806,000 163,624,000  35,500,000 -31,338,000 57,941,000  686,000 -1,137,000 29,042,000  -12,238,000 2,641,000 34,269,000  2,399,000 -1,158,000 44,135,000  32,831,000 1,581,000 28,877,000  26,821,000 554,000 21,598,000 15,675,000  67,520,000 7,527,000 19,306,000  -18,575,000 24,602,000 4,404,000  -3,522,000 1,970,000 5,991,000   
      interest paid
    		10,378,000 11,501,000 10,377,000 11,876,000 11,881,000 13,670,000 13,582,000 15,960,000 16,124,000 17,582,000 17,700,000 15,454,000 3,562,000 25,085,000 17,798,000 15,092,000 3,389,000 33,363,000 4,504,000 36,852,000 5,571,000 25,861,000 18,272,000 28,067,000 19,966,000 28,277,000 20,808,000 28,240,000 20,907,000 24,793,000 24,375,000 25,106,000 24,298,000 30,594,000 17,356,000 18,922,000 18,337,000 20,265,000 18,317,000 18,106,000 22,444,000 13,867,000 14,771,000 18,070,000 14,690,000 14,826,000 15,492,000 17,625,000 18,133,000 18,391,000 6,474,000 12,713,000 2,589,000 13,201,000 3,182,000 8,051,000 
      income taxes paid
    		21,835,000 3,253,000 18,605,000 14,821,000 15,030,000 3,661,000 21,031,000 13,488,000 13,154,000 11,964,000 11,943,000 13,890,000 1,799,000 3,591,000 21,836,000 18,753,000 2,388,000 4,704,000 10,859,000 16,636,000 2,182,000 9,390,000 6,557,000 12,848,000 1,807,000 8,393,000 16,626,000 2,110,000 334,000 7,579,000 7,824,000 6,807,000 2,230,000 22,872,000 18,384,000 5,386,000 1,357,000 6,338,000 5,307,000 1,793,000 1,914,000 707,000 1,259,000 1,293,000 7,811,000 657,000 3,441,000 6,527,000 249,000 407,000 166,000 6,855,000 5,635,000 209,000 342,000 422,000 
      loss on sale or disposal of property and equipment
    		                                                        
      impairment loss
    		                                                        
      changes in operating assets and liabilities, net of effects from acquisition:
    		                                                        
      acquisitions and other
    		                                                        
      net cash from investing activities
    		  -3,479,000 -9,816,000 -2,027,000 -2,130,000 -15,004,000 -4,496,000 -2,934,000 2,323,000 -1,803,000 -2,376,000 -1,047,000 -3,293,000 -20,229,000 -231,666,000 -1,323,000 -4,896,000 -5,728,000 -9,066,000 -2,553,000 -8,265,000 -2,483,000 -3,866,000 -1,956,000 -3,341,000 -2,065,000 63,307,000 -2,469,000 -2,876,000 -4,871,000 -2,231,000 -1,584,000 -804,881,000 59,262,000 51,919,000 -895,000 -228,012,000 6,380,000 -903,000 -436,000 -78,487,000 -106,000 -339,000 -56,169,000 -1,362,000 -1,346,000 18,044,000 -4,068,000 -1,409,000 -663,048,000 -51,000 969,000 -76,000 -130,000  
      borrowings under revolving credit agreement
    		          0 0 20,000,000 0 0 0 85,000,000 0    55,000,000 15,000,000 15,000,000 15,000,000 0 15,000,000 10,000,000 20,000,000 10,000,000    90,000,000 0   100,000,000 0 0 15,000,000 65,000,000 0 0   0 15,000,000 8,000,000 25,000,000       
      repayments under revolving credit agreement
    		          0 -10,000,000 -10,000,000 0 -20,000,000   0 -15,000,000 0 -55,000,000 0 -44,000,000 -41,000,000 -35,000,000 0 -15,000,000 -10,000,000 -20,000,000 -5,000,000    0 -65,000,000   -15,000,000 -26,100,000 -20,000,000 -35,000,000 -30,000,000 -37,500,000 -10,000,000 -17,500,000 -18,000,000 -7,000,000 0 0 -8,000,000       
      payment of debt costs
    		                                                        
      net cash from financing activities
    		  -11,488,000 -53,865,000 -51,200,000 -65,522,000 -68,444,000 -64,843,000 -53,549,000 -54,179,000 -10,021,000 -47,956,000 -47,374,000 -54,115,000 -67,638,000 50,534,000 63,650,000 -83,709,000 -9,044,000 -75,304,000 -111,362,000 20,557,000 -55,676,000 -47,022,000 -49,290,000 -45,000,000 -53,097,000 -99,852,000 -51,379,000 -64,346,000 -40,000,000 -54,015,000 -50,594,000 774,553,000 -65,015,000 -100,232,000 -47,449,000 167,540,000 -25,898,000 -44,719,000 -42,887,000 36,056,000 -96,695,000 42,602,000 30,737,000 -17,797,000 -30,077,000 -77,120,000 -17,000,000 -27,920,000 658,133,000 -17,999,000 -16,992,000 -22,708,000 -28,574,000  
      cash and cash equivalents - beginning of year
    		                                                        
      cash and cash equivalents - end of year
    		                                                        
      acquisition and other
    		                                                        
      payments of debt costs
    		              0                                          
      decrease in cash and cash equivalents
    		     -12,213,000                                            -14,611,000    -7,343,000   
      deferred income taxes
    		      8,178,000 5,171,000 5,449,000 4,272,000 9,810,000 2,998,000 1,213,000 -1,317,000 3,657,000 1,763,000 5,876,000 10,658,000 4,314,000 -2,491,000 6,147,000 6,469,000 1,556,000 1,621,000 4,206,000 -43,863,000 2,970,000 -6,416,000 6,755,000 -12,236,000 -273,171,000 7,096,000 9,225,000 6,752,000 -1,928,000 -942,000 -9,660,000 14,561,000 9,606,000 10,449,000 11,536,000 7,140,000 8,751,000 5,906,000 -2,442,000 6,797,000 9,526,000 3,588,000 5,315,000 7,076,000 6,472,000 1,359,000 2,776,000 3,186,000 2,038,000 4,338,000 
      loss on extinguishment of debt
    		             0 0       0                17,519,000 0 0 451,000  3,274,000            300,000  
      proceeds from refinancing of term loan
    		             0 0                                          
      acquisition of akorn
    		                                                        
      changes in operating assets and liabilities
    		                                                        
      escrow receipt
    		                     0                                   
      acquisitions
    		             -132,000                                           
      proceeds from issuance of senior notes
    		                                                        
      repayment of senior notes
    		                                                        
      gain on divestitures
    		                                                        
      proceeds from divestitures
    		                                 0                       
      acquisition of tradename
    		                                                        
      proceeds from issuance of 5.125% senior notes
    		                                                        
      repayment of 5.375% senior notes
    		                                                        
      interest expense relating to finance lease liability
    		                   59,000 50,000                                    
      interest expense relating to rou assets
    		                     50,000                                   
      lease termination costs
    		                             0                 0 0         
      other non-cash items
    		                                                        
      changes in operating assets and liabilities, net of effects from acquisitions and divestitures:
    		                                                        
      prepaid expenses and other assets
    		                                                        
      proceeds from issuance of 2016 senior notes
    		                                                        
      proceeds from issuance of 2019 senior notes
    		                                                        
      repayment of 2013 senior notes
    		                                                        
      payments of debt origination costs
    		                                 -11,131,000 0 0 -9,000 -7,617,000 0 -39,000 -4,172,000                
      gain on divestiture
    		                          0                              
      proceeds from divestiture
    		                          0                              
      (gain) loss on divestitures
    		                                                        
      excess tax benefits from share-based awards
    		                              0 168,000 302,000 100,000 0 250,000 550,000 110,000 0 250,000 1,600,000 950,000 -75,000 375,000 898,000 452,000           
      changes in operating assets and liabilities, net of effects from acquisitions:
    		                                                        
      pension contribution
    		                                                        
      proceeds from the sale of property, plant and equipment
    		                                                        
      proceeds from working capital arbitration settlement
    		                                                        
      acquisition of c.b. fleet, less cash acquired
    		                                                        
      acquisition of c.b. fleet escrow receipt
    		                                                        
      proceeds from issuance of term loan
    		                                                        
      write-off of indemnification asset
    		                                                        
      pension and deferred compensation contribution
    		                             -106,000                           
      acquisition of fleet escrow receipt
    		                                                        
      loss on divestitures
    		                                                        
      gain on sale or disposal of property and equipment
    		                                                        
      long term income taxes payable
    		                                                        
      premium payment on 2012 senior notes
    		                                                        
      acquisition of dentek, less cash acquired
    		                                                        
      repayment of 2012 senior notes
    		                                                        
      borrowings under bridge term loans
    		                                                        
      repayments under bridge term loans
    		                                                        
      proceeds from restricted stock exercises
    		                                     0 0 0 544,000 57,000               
      loss on disposals of property and equipment
    		                              49,000 971,000 490,000                        
      noncurrent assets and liabilities
    		                              -358,000 342,000 -287,000                        
      acquisition of fleet escrow payment
    		                              0 0 970,000                        
      proceeds from the sales of property, plant and equipment
    		                                                        
      proceeds from dentek working capital arbitration settlement
    		                                 0                       
      proceeds from sales of intangible assets
    		                                                        
      loss on divestitures and sales of property and equipment
    		                                 13,000                       
      gain on sale of asset
    		                                        -36,000                
      purchases of property and equipment
    		                                 -1,042,000 -531,000 -509,000 -895,000 -1,028,000 -857,000 -903,000 -780,000 -496,000 -106,000 -339,000 -955,000 -1,364,000 -1,346,000 -3,656,000 -4,068,000 -1,198,000       
      proceeds from the sale of property and equipment
    		                                     0 0 0 344,000   0 1,000 2,000           
      proceeds from sale of asset
    		                                                        
      proceeds from insight pharmaceuticals working capital arbitration settlement
    		                                     0                   
      acquisition of insight pharmaceuticals, less cash acquired
    		                                                        
      acquisition of the hydralyte brand
    		                                         -77,991,000               
      term loan repayments resulting from refinancing
    		                                                        
      proceeds from the sales of property and equipment
    		                                                        
      gain on sales of intangible assets and property and equipment
    		                                                        
      changes in operating assets and liabilities, net of effects from acquisitions
    		                                                        
      gain on sale of assets
    		                                    55,453,000                    
      premium payment on 2010 senior notes
    		                                          -2,759,000              
      (gain) loss on sale or disposal of property and equipment
    		                                     1,000     0              
      proceeds from sale of business
    		                                                        
      acquisition of care pharmaceuticals, less cash acquired
    		                                          0 0             
      proceeds from issuance of 2013 senior notes
    		                                                        
      repayment of 2010 senior notes
    		                                          -48,290,000              
      term loan borrowings
    		                                                        
      amortization of deferred financing costs
    		                                         851,000 1,079,000 4,048,000 1,083,000 892,000 1,612,000 6,160,000 1,012,000 1,048,000 783,000 282,000 282,000 283,000 255,000 527,000 
      amortization of debt discount
    		                                         144,000 295,000 2,317,000 453,000 345,000 740,000 3,080,000 408,000 404,000 343,000 229,000 229,000 229,000 142,000  
      proceeds from sale of property and equipment
    		                                                0 15,000       
      proceeds from the sale of phazyme brand
    		                                                        
      acquisition of brands from gsk purchase price adjustments
    		                                              0 0 0 -226,000       
      payment of deferred financing costs
    		                                         -74,000 -533,000 -6,658,000 5,000 -280,000         -112,000  
      (gain) on sale or disposal of property and equipment
    		                                                        
      proceeds from escrow of blacksmith acquisition
    		                                                  0 0     
      acquisition of brands from gsk
    		                                                        
      proceeds from issuance of 2012 term loan
    		                                                        
      repayment of 2010 term loan
    		                                                        
      repayment of 2012 term loan
    		                                                        
      proceeds from the sale of the phazyme brand
    		                                                        
      proceeds from the issuance of 2013 senior notes
    		                                                        
      repayments of long-term debt
    		                                           -140,000,000    -97,500,000 -25,000,000 -45,000,000       
      (gain) loss on sale or disposal of equipment
    		                                            -1,000 -2,000           
      loss on sale of discontinued operations
    		                                                        
      loss on disposal of equipment
    		                                              52,000 0 30,000 21,000       
      proceeds from sale of discontinued operations
    		                                                        
      acquisition of blacksmith, net of cash acquired
    		                                                        
      acquisition of dramamine
    		                                                        
      proceeds from issuance of 2012 term loan and 2010 term loan
    		                                                        
      repayment of long-term debt
    		                                                  33,000,000 -18,000,000 -17,000,000 -23,000,000 -28,462,000  
      shares surrendered as payment of tax withholding
    		                                                  0 0 0 -271,000   
      cash - beginning of year
    		                                                        
      cash - end of year
    		                                                        
      gain on sale of discontinued operations
    		                                                        
      impairment of goodwill and intangible assets
    		                                                        
      purchases of equipment
    		                                                  -248,000 -51,000 -231,000 -76,000 -130,000  
      acquisition of gsk brands
    		                                                        
      proceeds from issuance of debt
    		                                                        
      increase in cash
    		                                                      -7,991,000 8,611,000 
      inventories held for sale
    		                                                        
      proceeds from issuance of senior term loan
    		                                                        
      business acquisition purchase price adjustments
    		                                                        
      1.
    		                                                        
      loss on disposition of equipment
    		                                                      125,000  
      income taxes payable
    		                                                        
      cash - beginning of period
    		                                                      41,097,000 5,334,000 
      cash - end of period
    		                                                      33,106,000 13,945,000 
      machinery
    		                                                      5,000  
      computer equipment
    		                                                      3,000  
      furniture and fixtures
    		                                                      7,000  
      changes in operating assets and liabilities, net of effects of purchases of businesses
    		                                                        
      account payable – related parties
    		                                                        
      accrued expenses
    		                                                        
      purchase of equipment
    		                                                        
      purchase of business, net of cash acquired
    		                                                        
      proceeds from the issuance of notes
    		                                                        
      repayment of notes
    		                                                        
      proceeds from the issuance of preferred and common units
    		                                                        
      additional costs associated with initial public offering
    		                                                        
      supplemental cash flow information
    		                                                        
      fair value of assets acquired, net of cash acquired
    		                                                        
      fair value of liabilities assumed
    		                                                        
      purchase price funded with non-cash contributions
    		                                                        
      cash paid to purchase business
    		                                                        
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.